Cite
HARVARD Citation
Roug, A. et al. (n.d.). HMICL and CD123 in combination with a CD45/CD34/CD117 backbone – a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia. British journal of haematology. pp. 212-222. [Online].